Literature DB >> 2175446

The prevalence of antibody to human parvovirus B19 in Rio de Janeiro, Brazil.

J P Nascimento1, M M Buckley, K E Brown, B J Cohen.   

Abstract

During 1985 and 1986 serum samples were collected from the Rio de Janeiro population and examined for the presence of IgG antibody to human parvovirus B19. No difference in prevalence was found between males and females. Antibody prevalence rose from 35% in children less than five years old to almost 80% in children aged eleven to fifteen years. The antibody prevalence in individuals over 50 years old was over 90%.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2175446     DOI： 10.1590/s0036-46651990000100007

Source DB:  PubMed          Journal:  Rev Inst Med Trop Sao Paulo        ISSN： 0036-4665            Impact factor:   1.846


  9 in total

Review 1.  Parvovirus B19 infection in human pregnancy.

Authors:  R F Lamont; J D Sobel; E Vaisbuch; J P Kusanovic; S Mazaki-Tovi; S K Kim; N Uldbjerg; R Romero
Journal:  BJOG       Date:  2010-10-13       Impact factor: 6.531

2.  History of Parvovirus B19 infection is associated with a DNA methylation signature in childhood acute lymphoblastic leukemia.

Authors:  Gisele M Vasconcelos; Brock C Christensen; E Andrés Houseman; Jianqiao Xiao; Carmen J Marsit; John K Wiencke; Shichun Zheng; Margaret R Karagas; Heather H Nelson; Margaret R Wrensch; Karl T Kelsey; Maria S Pombo-de-Oliveira; Joseph L Wiemels
Journal:  Epigenetics       Date:  2011-12       Impact factor: 4.528

3.  Long term follow up of serostatus after maternofetal parvovirus B19 infection.

Authors:  J Dembinski; A M Eis-Hübinger; J Maar; R Schild; P Bartmann
Journal:  Arch Dis Child       Date:  2003-03       Impact factor: 3.791

Review 4.  Parvovirus B19 infection.

Authors:  J R Kerr
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-01       Impact factor: 3.267

5.  Parvovirus B19 infection in five European countries: seroepidemiology, force of infection and maternal risk of infection.

Authors:  J Mossong; N Hens; V Friederichs; I Davidkin; M Broman; B Litwinska; J Siennicka; A Trzcinska; P VAN Damme; P Beutels; A Vyse; Z Shkedy; M Aerts; M Massari; G Gabutti
Journal:  Epidemiol Infect       Date:  2007-10-24       Impact factor: 2.451

6.  Model structure analysis to estimate basic immunological processes and maternal risk for parvovirus B19.

Authors:  Nele Goeyvaerts; Niel Hens; Marc Aerts; Philippe Beutels
Journal:  Biostatistics       Date:  2010-09-14       Impact factor: 5.899

7.  Seroprevalence of parvovirus B19 antibodies and evidence of viremia among Nigerian patients with sickle cell anemia.

Authors:  Bamidele Abiodun Iwalokun; Senapon Olusola Iwalokun; Semande Olufunmilayo Hodonu
Journal:  J Biomed Res       Date:  2013-06-15

8.  Pure Red Cell Aplasia Following Interleukin-2 Therapy.

Authors:  Janice P Dutcher; Wen Fan; Peter H Wiernik
Journal:  J Investig Med High Impact Case Rep       Date:  2016-04-11

9.  Prevalence and Phylogenetic Analysis of Parvovirus (B19V) among Blood Donors with Different Nationalities Residing in Qatar.

Authors:  Doua Abdelrahman; Duaa W Al-Sadeq; Maria K Smatti; Sara A Taleb; Raed O AbuOdeh; Enas S Al-Absi; Asmaa A Al-Thani; Peter V Coyle; Nader Al-Dewik; Ahmed A Al Qahtani; Hadi M Yassine; Gheyath K Nasrallah
Journal:  Viruses       Date:  2021-03-24       Impact factor: 5.048
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.